Hydration Pharmaceuticals Co. Ltd. (AU:HPC) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Hydration Pharmaceuticals Co. Ltd. has reported that Nicholas Berry was appointed as a director on May 25, 2024, and holds significant interests, with 60,952,123 ordinary shares, 52,442,532 unlisted warrants, and 6,686,844 unlisted options through Pure Asset Management. Additionally, the company has disclosed contracts with Pure Asset Management, including a multi-tranche secured loan facility and variations allowing further funding options.
For further insights into AU:HPC stock, check out TipRanks’ Stock Analysis page.

